PARP INHIBITOR
Clinical trials for PARP INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new PARP INHIBITOR trials appear
Sign up with your email to follow new studies for PARP INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for brain cancer: drug combo targets tough tumors
Disease control OngoingThis study tests whether adding the drug olaparib to standard radiation and chemotherapy can help people with aggressive, inoperable brain tumors live longer. About 91 participants will receive the combination treatment. The goal is to find the best dose and see if it improves su…
Matched conditions: PARP INHIBITOR
Phase: PHASE1, PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated May 26, 2026 10:10 UTC
-
Lung cancer clue: could a DNA glitch open door to new treatments?
Knowledge-focused OngoingThis study examines how often a specific DNA repair issue (HRD) occurs in people with a certain type of advanced lung cancer (EGFR-mutated NSCLC). Researchers will analyze tumor samples from 100 participants to see if this issue is linked to how the cancer behaves. The goal is to…
Matched conditions: PARP INHIBITOR
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 26, 2026 10:17 UTC